Drug intelligence / Profile preview

Shumian capsules

Development stage
Phase 4
Lead developer
Guizhou Dalong Pharmaceutical
Administration
Oral
01

Overview

Shumian capsules (also known as Shumian capsule or SMC) are a proprietary traditional Chinese medicine (TCM) capsule used to treat insomnia, including insomnia with depression or anxiety. The formula is a multi-herb botanical mixture of eight herbs: Ziziphi Spinosae Semen (Suanzaoren), Bupleuri Radix (Chaihu), Paeoniae Radix Alba (Baishao), Albiziae Flos (Hehuanhua), Albiziae Cortex (Hehuanpi), Bombyx batryticatus (Jiangcan), Cicadae Periostracum (Chantui), and Junci Medulla (Dengxincao). Developed and manufactured by Guizhou Dalong Pharmaceutical, Shumian capsules soothe the liver, relieve depression, and calm the mind. Preclinical studies suggest that its sedative and antidepressant effects are mediated through the activation of melatonin receptors MT1 and MT2, as well as the modulation of orexin receptors OX1R and OX2R. Clinical trials have demonstrated that Shumian capsules significantly improve sleep quality (as measured by PSQI, ISI, and polysomnography) and reduce symptoms of depression and anxiety in patients with insomnia.

Brand names
Dalong
Other names
SMSMCShumian capsuleShumian jiaonang
02

Targets

MTNR1A (MT1)MTNR1B (Melatonin Receptor 2)

Beyond the preview

Go deeper on Shumian capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shumian capsules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call